Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis

Molecular Neurobiology

Volumn 53, Issue 2, 2016, Pages 1045-1051

  Yu, Shuai ^a   Chen, Ying ^a   Hou, Xu ^a   Xu, Donghua ^b   Che, Kui ^a   Li, Changgui ^d   Yan, Shengli ^a   Wang, Yangang ^a   Wang, Bin ^a,c  

^a QINGDAO UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Essencemed Clinic   (China)

^d Affiliated Hospital of Qingdao Medical University   (China)

Author keywords

Diabetic peripheral neuropathy; Hyperuricemia; Uric acid

Indexed keywords

URIC ACID;

ARTICLE; BLOOD ANALYSIS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; HUMAN; HYPERURICEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; BLOOD; COMPLICATION; META ANALYSIS; PUBLISHING;

DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; HYPERURICEMIA; PUBLICATION BIAS; RISK FACTORS; URIC ACID;

EID: 84958170741     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-9075-0     Document Type: Article

References (46)

1. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11(6):521–534
2. Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28 Suppl:18–14
3. Smith SC, Lamping DL, Maclaine GD (2012) Measuring health-related quality of life in diabetic peripheral neuropathy: a systematic review. Diabetes Res Clin Pract 96(3):261–270
4. Monteiro-Soares M, Vaz-Carneiro A, Sampaio S, Dinis-Ribeiro M (2012) Validation and comparison of currently available stratification systems for patients with diabetes by risk of foot ulcer development. Eur J Endocrinol 167(3):401–407
5. Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C, Matfin G, Wu X (2013) Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One 8(10):e78206
6. Han T, Bai J, Liu W, Hu Y (2012) A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 167(4):465–471
7. Gonzalez R, Pedro T, Martinez-Hervas S, Civera M, Priego MA, Catala M, Chaves FJ, Ascaso JF, Carmena R, Real JT (2012) Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects. J Peripher Nerv Syst 17(2):191–196
8. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ (2011) Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 34(10):2220–2224
9. Martinon F (2010) Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 233(1):218–232
10. Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25(2):210–216
11. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA (2013) Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62(10):3307–3315
12. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K (2002) Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51(9):2817–2825
13. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62(2):170–180
14. Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S (2014) Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. J Diabetes Complicat 28(2):124–129
15. Kiani J, Habibi Z, Tajziehchi A, Moghimbeigi A, Dehghan A, Azizkhani H (2014) Association between serum uric acid level and diabetic peripheral neuropathy (a case control study). Caspian J Intern Med 5(1):17–21
16. Papanas N, Katsiki N, Papatheodorou K, Demetriou M, Papazoglou D, Gioka T, Maltezos E (2011) Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62(4):291–295
17. Lu B, Hu J, Wen J, Zhang Z, Zhou L, Li Y, Hu R (2013) Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes—ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One 8(4):e61053
18. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ (2003) Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 20(2):105–113
19. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site
20. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
24. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
25. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, La Placa S, Di Gati M, Licata G (2008) Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism 57(5):676–682
26. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, Togane M (2011) Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 6(11):e27817
27. Meng L, Zhu J (2008) An analysis of clinical features of accompanying periphery neuropathy in 132 cases with type 2 diabetes [article in Chinese]. J Xinjiang Med Univ 31(5):515–520
28. Guo L, Luo Y, Liu W, Luan J, Yang H, Chen B (2012) Level of UA and related factors in DPN patients [article in Chinese]. Anhui Med Pharma J 16(1):73–75
29. Sang Y (2012) Relationship between serum uric acid and microvascular complications in patients with type 2 diabetes mellitus [article in Chinese]. J Med Forum 33(8):25–26
30. Wang S (2012) Correlation analysis between the hyperuricemia and diabetic peripheral neuropathy [article in Chinese]. China Med Pharm 2(5):169–170
31. Wei X, Wu W (2012) The correlation analysis of hyperuricemia and vascular complications of type II diabetes [article in Chinese]. Med J West China 24(5):891–895
32. Xin S, Zhang L (2012) Correlation ship of serum uric acid with type 2 diabetic peripheral neuropathy [article in Chinese]. Clin Med 32(9):26–27
33. Gong L, Huang Y, Feng F (2013) Analysis of the risk factors in type 2 diabetics with hyperuricaemia [article in Chinese]. Acta Acad Med Wannan 32(4):304–306
34. Premkumar LS, Pabbidi RM (2013) Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species. Cell Biochem Biophys 67(2):373–383
35. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2009) Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61(7):885–892
36. Petta S, Camma C, Cabibi D, Di Marco V, Craxi A (2011) Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 34(7):757–766
37. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, Chien KL, Hwang LC, Su TC, Tseng CH, Sun CA (2012) Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220(2):525–531
38. Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C (2012) Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 41(3):450–457
39. Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, Lee J, Lee MY, Lee SM, Kang DH, Lee BH (2014) Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J 28(7):3197–3204
40. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, Takishita S (2004) Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 27(11):835–841
41. Krishnan E, Akhras KS, Sharma H, Marynchenko M, Wu EQ, Tawk R, Liu J, Shi L (2013) Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM 106(8):721–729
42. Papanas N, Demetriou M, Katsiki N, Papatheodorou K, Papazoglou D, Gioka T, Kotsiou S, Maltezos E, Mikhailidis DP (2011) Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus. Exp Diabetes Res 1–5
43. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S (2014) Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 63(3):976–981
44. Stamp LK, Turner R, Khalilova IS, Zhang M, Drake J, Forbes LV, Kettle AJ (2014) Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia. Rheumatology (Oxford)
45. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal diaease? Hypertension 41(6):1183–1190
46. Papezikova I, Pekarova M, Kolarova H, Klinke A, Lau D, Baldus S, Lojek A, Kubala L (2013) Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res 47(2):82–88